Deep venous thrombosis (DVT) is a part of venous thromboembolism (VTE) that clinically
manifests as swelling and pain in the lower limbs. The most serious clinical complication of …

Both neutrophil extracellular traps (NETs) and von Willebrand factor (VWF) are essential for
thrombosis and inflammation. During these processes, a complex series of events, including …

Background Deletion of Toll-like receptor 9 (Tlr9) signaling, which is important for sterile
inflammatory processes, results in impaired resolution of venous thrombosis (VT) in mice …

Deep vein thrombosis (DVT) and its devastating complication, pulmonary embolism, are a
severe health problem with high mortality. Mechanisms of thrombus formation in veins …

Severe fibrotic and thrombotic events permeate the healthcare system, causing suffering for
millions of patients with inflammatory disorders. As late-state consequences of chronic …

Deep vein thrombosis and common complications, including pulmonary embolism and post-
thrombotic syndrome, represent a major source of morbidity and mortality worldwide …

Deep vein thrombosis (DVT) is a common clinical problem, but its cellular and molecular
mechanisms remain incompletely understood. In this study, we performed single-cell RNA …

Background Although the concept of immunothrombosis has established a link between
inflammation and thrombosis, the role of inflammation in the pathogenesis of deep vein …

Much research in venous thrombotic diseases focuses on the acute thrombotic process such
as anticoagulation and risk factors. Deep-vein thrombosis directly leads to post thrombotic …

Deep vein thrombosis (DVT) affects up to 2 million people in the United States, and
worldwide incidence is 70 to 113 cases per 100,000 per year. Mortality from DVT is often …